Cat. No. 4758
Chemical Name: N-[(6-3-Methanesulfonamido-4-methyl
Biological ActivityBroad spectrum bromodomain inhibitor. Accelerates FRAP recovery of BRD4 and CREBBP in cells at a concentration of 1 μM.
Licensing InformationThis compound is supplied in conjunction with the Structural Genomics Consortium. For further characterization details, please visit the Bromosporine probe summary on the SGC website.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Gallenkamp et al (2014) Bromodomains and their pharmacological inhibitors. ChemMedChem 9 438. PMID: 24497428.
If you know of a relevant reference for Bromosporine please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Bromosporine from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Bromosporine, supplier, broad, spectrum, bromodomain, inhibitors, inhibits, BRD, sgc, Tocris Bioscience, Bromodomain Inhibitor products
Find multiple products by catalog number
New Products in this Area
BET bromodomain inhibitor; orally bioavailableH3K4(Me2) (1-20)
Histone H3 peptideTC AC 28
High affinity BET bromodomain ligandTP 472N
Negative control for TP 472 (Cat. No. 6000).
Tocris has a collaboration with the Structural Genomics Consortium (SGC) to provide the latest high quality epigenetics probes.